Podocyte-specific expression of organic cation transporter PMAT: Implication in puromycin aminonucleoside nephrotoxicity

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 6, 2009, Pages

  Xia, Li ^a,b   Zhou, Mingyan ^a   Kalhorn, Thomas F ^a   Ho, Horace T B ^a   Wang, Joanne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Decynium 22; Equilibrative nucleoside transporter 4; Glomerulopathy; Kidney

Indexed keywords

AMINO ACID; ORGANIC CATION TRANSPORTER; PLASMA MEMBRANE MONOAMINE TRANSPORTER; POLYCLONAL ANTIBODY; PUROMYCIN AMINONUCLEOSIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLOMERULUS; GLOMERULUS EPITHELIUM; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; KIDNEY; KIDNEY TUBULE; NEPHROTOXICITY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIVITY ANALYSIS;

EID: 66449091213     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00046.2009     Document Type: Article

References (31)

1. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MW, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR, Baldwin SA. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99: 510-519, 2006. (Pubitemid 44337823)
2. Bek M, Fischer KG, Greiber S, Hupfer C, Mundel P, Pavenstadt H. Dopamine depolarizes podocytes via a D1-like receptor. Nephrol Dial Transplant 14: 581-587, 1999. (Pubitemid 29105982)
3. Chen Y, Zhang S, Sorani M, Giacomini KM. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther 322: 695-700, 2007.
4. Engel K, Wang J. Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68: 1397-1407, 2005. (Pubitemid 41539995)
5. Engel K, Zhou M, Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279: 50042-50049, 2004. (Pubitemid 39577815)
6. Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95: 25-36, 2006.
7. Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11: 383-393, 2000. (Pubitemid 30115068)
8. Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Arch 447: 666-676, 2004. (Pubitemid 38241452)
9. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab 5: 63-84, 2004. (Pubitemid 38279408)
10. Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res 264: 74-99, 2001. (Pubitemid 32989083)
11. Li H, Smolen GA, Beers LF, Xia L, Gerald W, Wang J, Haber DA, Lee SB. Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor. PLoS ONE 3: e2353, 2008.
12. Li M, Anderson GD, Wang J. Drug-drug interactions involving membrane transporters in the human kidney. Expert Opin Drug Metab Toxicol 2: 505-532, 2006. (Pubitemid 46127070)
13. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int 58: 598-606, 2000. (Pubitemid 30620009)
14. Masereeuw R, Russel FG. Mechanisms and clinical implications of renal drug excretion. Drug Metab Rev 33: 299-351, 2001. (Pubitemid 33136267)
15. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 102: 17923-17928, 2005. (Pubitemid 41798478)
16. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009.
17. Pritchard JB, Miller DS. Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73: 765-796, 1993. (Pubitemid 24004652)
18. Quaggin SE. Transcriptional regulation of podocyte specification and differentiation. Microsc Res Tech 57: 208-211, 2002. (Pubitemid 34553250)
19. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8: 219-232, 1975.
20. Saleem MA. Biology of the human podocyte. Nephron Exp Nephrol 95: e87-e92, 2003.
21. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006. (Pubitemid 43882099)
22. Steinhausen M, Weis S, Fleming J, Dussel R, Parekh N. Responses of in vivo renal microvessels to dopamine. Kidney Int 30: 361-370, 1986. (Pubitemid 16029506)
23. Sweet DH. Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol Appl Pharmacol 204: 198-215, 2005. (Pubitemid 40545228)
24. Takano K, Kawasaki Y, Imaizumi T, Matsuura H, Nozawa R, Tannji M, Suyama K, Isome M, Suzuki H, Hosoya M. Development of glomerular endothelial cells, podocytes and mesangial cells in the human fetus and infant. Tohoku J Exp Med 212: 81-90, 2007. (Pubitemid 46711729)
25. Tryggvason K, Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med 254: 216-224, 2003. (Pubitemid 37070222)
26. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987-1049, 2004. (Pubitemid 38823772)
27. Xia L, Engel K, Zhou M, Wang J. Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Renal Physiol 292: F682-F690, 2007. (Pubitemid 46220537)
28. Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol 74: 477-487, 2007. (Pubitemid 46963232)
29. Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA. The dopaminergic system in hypertension. Clin Sci (Lond) 112: 583-597, 2007. (Pubitemid 46849549)
30. Zhou M, Xia L, Engel K, Wang J. Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family. J Biol Chem 282: 3188-3195, 2007. (Pubitemid 47084340)
31. Zhou M, Xia L, Wang J. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35: 1956-1962, 2007. (Pubitemid 47481592)